Clinical Trials Radar
ClinicalTrials.gov
All sponsors

University of Illinois at Urbana-Champaign

illinois.edu

Total trials

187

Active

26

Phase 3

1

Total enrollment

28,483

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 2 of 2 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Alcohol—————3
Alcohol beverage—————1

Next readouts

  • 2026-08-01
  • 2027-01
  • 2028-07

Top conditions

  • Obesity23
  • Multiple Sclerosis15
  • Aging11
  • Cognitive Change8
  • Physical Activity8
  • Diet Habit7
  • Breast Cancer6
  • Weight Loss6

Frequently asked questions about University of Illinois at Urbana-Champaign

How many clinical trials does University of Illinois at Urbana-Champaign have on ClinicalTrials.gov?
University of Illinois at Urbana-Champaign is listed as the lead sponsor on 187 clinical trials in ClinicalTrials.gov, 26 of which are currently active (recruiting, enrolling, or ongoing).
How many of University of Illinois at Urbana-Champaign's trials are in Phase 3?
1 of University of Illinois at Urbana-Champaign's trials are in Phase 3, spread across 2 active drug programs.
What therapeutic areas does University of Illinois at Urbana-Champaign focus on?
University of Illinois at Urbana-Champaign's most-studied conditions on ClinicalTrials.gov are Obesity, Multiple Sclerosis, Aging, Cognitive Change, Physical Activity.
When are University of Illinois at Urbana-Champaign's next clinical trial readouts?
University of Illinois at Urbana-Champaign has 3 upcoming primary-completion readouts tracked here; the soonest is “Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms”, expected around 2026-08-01.